Erin Epson
Impact in
-
- Antibiotic Use and Resistance
- Infectious Diseases top 5%
- Antimicrobial Resistance in Staphylococcus
- Clostridium difficile and Clostridium perfringens research
Papers in
-
- Clostridium difficile and Clostridium perfringens research 4
- Antifungal resistance and susceptibility 3
-
- Antibiotic Use and Resistance 10
- Co-authors
- Shelley S. Magill (3 shared papers)Amy Heinzerling (2 shared papers)Seema Jain (2 shared papers)Kiran M. Perkins (2 shared papers)Jennifer R. Verani (1 shared paper)Ghinwa Dumyati (2 shared papers)Meileen Acosta (1 shared paper)Matthew J. Stuckey (1 shared paper)
- Journals
- Infection Control and Hospital Epidemiology (8 papers)Open Forum Infectious Diseases (7 papers)Clinical Infectious Diseases (3 papers)MMWR Morbidity and Mortality Weekly Report (2 papers)Emerging infectious diseases (2 papers)
- Partner nations
- United StatesUgandaFrance
In The Last Decade
Erin Epson
35 papers receiving 1.2k citations
Erin Epson's Hit Papers
Peers
Comparison fields: 5 of 114
- Applied Microbiology and Biotechnology 89
- Infectious Diseases 452
- Molecular Medicine 124
- Clinical Biochemistry 129
- General Dentistry 19
Countries citing papers authored by Erin Epson
This map shows the geographic impact of Erin Epson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erin Epson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erin Epson more than expected).
Fields of papers citing papers by Erin Epson
This network shows the impact of papers produced by Erin Epson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erin Epson. The network helps show where Erin Epson may publish in the future.
Co-authors
The 25 scholars most cited alongside Erin Epson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 41 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Vital Signs: Epidemiology and Recent Trends in Methicillin-Resistant and in Methicillin-Susceptible Staphylococcus aureus Bloodstream Infections — United States Hit paper breakdown → | 2019 | 512 |
| 2 | Transmission of COVID-19 to Health Care Personnel During Exposures to a Hospitalized Patient — Solano County, California, February 2020 Hit paper breakdown → | 2020 | 324 |
| 3 | 2014 | 52 | |
| 4 | 2017 | 34 | |
| 5 | 2018 | 30 | |
| 6 | 2014 | 29 | |
| 7 | 2016 | 28 | |
| 8 | 2018 | 25 | |
| 9 | 2019 | 21 | |
| 10 | 2016 | 16 | |
| 11 | 2012 | 15 | |
| 12 | 2022 | 13 | |
| 13 | 2015 | 9 | |
| 14 | 2022 | 8 | |
| 15 | 2019 | 8 | |
| 16 | 2015 | 8 | |
| 17 | 2021 | 8 | |
| 18 | 2016 | 6 | |
| 19 | 2012 | 6 | |
| 20 | 2017 | 4 |
About Erin Epson
Erin Epson is a scholar working on Infectious Diseases, Applied Microbiology and Biotechnology, Epidemiology, Clinical Biochemistry and Molecular Medicine, having authored 41 papers that have together received 1.2k indexed citations. Recurring topics across this work include Antibiotic Use and Resistance (10 papers), Antibiotic Resistance in Bacteria (6 papers), Bacterial Identification and Susceptibility Testing (6 papers), Clostridium difficile and Clostridium perfringens research (4 papers), Infection Control and Ventilation (3 papers), Patient Satisfaction in Healthcare (3 papers), Antifungal resistance and susceptibility (3 papers) and Mycobacterium research and diagnosis (3 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (89 citations), Infectious Diseases (452 citations), Molecular Medicine (124 citations), Clinical Biochemistry (129 citations) and General Dentistry (19 citations). Erin Epson has collaborated with scholars based in United States, Uganda and France. Frequent co-authors include Shelley S. Magill, Amy Heinzerling, Seema Jain, Kiran M. Perkins, Jennifer R. Verani, Ghinwa Dumyati, Meileen Acosta, Matthew J. Stuckey, Kerui Xu and Yi Mu. Their work appears in journals such as Infection Control and Hospital Epidemiology, Open Forum Infectious Diseases, Clinical Infectious Diseases, MMWR Morbidity and Mortality Weekly Report and Emerging infectious diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.